Meet us at Bio-Europe 2026
November 9 – 11, 2026 | Cologne, Germany
Patient x Target x ModalityPartnering in oncology R&D starts with the right fit
BIO-Europe brings biopharma leaders, investors, and partners to Cologne to build the collaborations that move programs forward.
At Indivumed, every program defines patient, target and modality together, rooted in tumor biology captured in the operating room. Tumor and matched normal tissue, collected under standardized conditions, result in complex multi-omics data that we combine with clinical data from the same patient. This is human evidence to rely on when programs pick their targets.
Our Director BD Strategy, Dr. Sachli Safari, will be in Cologne throughout the event. Let’s connect!